A proposal for value informed, affordable (“via”) prices for innovative medicines-Reference-Cited by-同舟云学术

A proposal for value informed, affordable (“via”) prices for innovative medicines

Published:2019-07-08 Issue:11 Volume:22 Page:1235-1239
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Annemans Lieven¹

Affiliation:

1. Faculty of Medicine, Ghent University, Ghent, Belgium

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2019.1632203

Reference40 articles.

1. Council of the European Union. Council Conclusions on Innovation for the Benefit of Patients. Official Journal of the European Union. December 2014.

2. Valorising and Creating Access to Innovative Medicines in the European Union

3. Ministerial Statement ‘The next generation of health reforms’. OECD Health Ministerial Meeting. 17 January 2017. Available from: http://www.oecd.org/health/ministerial/ministerial-statement-2017.pdf [Accessed 15 April 2019].

4. Outrageous prices of orphan drugs: a call for collaboration

5. Pricing in the Market for Anticancer Drugs

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is a fair price for a medicine? Establishing the main elements of a fair price based on the current policy debate;Public Health;2024-06

2. Inequities in kidney health and kidney care;Nature Reviews Nephrology;2023-08-14

3. Innovative Public Price Mechanisms for Market Access of Innovative Medicines: A Marriage Between Cost-Effectiveness, Medical Need, and Budget Impact;Value in Health;2023-03

4. Critical Reflections on Reimbursement and Access of Advanced Therapies;Frontiers in Pharmacology;2022-05-18

5. Evidence-based public policy making for medicines across countries: findings and implications for the future;Journal of Comparative Effectiveness Research;2021-08